Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Conversion of 1,770,805 SER shares, $3.98M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Serina Therapeutics, Inc. (SER) | Conversion | 1,770,805 | $3.98M |
| May 1, 2026 | Biohaven Ltd. (BHVN) | Grant/Award | 68,693 | n/a |
| Apr 21, 2026 | Serina Therapeutics, Inc. (SER) | Grant/Award | 59,667 | $115.8K |
| Nov 17, 2025 | Biohaven Ltd. (BHVN) | Purchase | 400,000 | $3.00M |
| Nov 11, 2025 | Serina Therapeutics, Inc. (SER) | Grant/Award | 10,000 | n/a |
| May 7, 2025 | Biohaven Ltd. (BHVN) | Grant/Award | 31,716 | n/a |
| Apr 10, 2025 | Serina Therapeutics, Inc. (SER) | Grant/Award | 762,548 | $3.95M |
| Dec 19, 2024 | Serina Therapeutics, Inc. (SER) | Purchase | 3,866 | $17.7K |
| Sep 25, 2024 | Biohaven Ltd. (BHVN) | Purchase | 5,000 | $221.0K |
| Sep 24, 2024 | Serina Therapeutics, Inc. (SER) | Purchase | 1,137 | $6.9K |